Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Teva

Teva Leans Into Sanofi's 'Pipeline-In-A-Product' Expertise In $1.5 Billion Deal

Teva stock tumbled Wednesday after the company announced it would partner with Sanofi to develop an inflammatory bowel disease treatment.

Investors Business Daily

Prescribe to Profits With These 3 Pharma Stocks

The pharma industry looks well-positioned for solid growth in the long term amid the rising incidence of chronic illnesses and technological advancements. So, quality pharma stocks, Eli Lilly and Company (LLY), Merck & Co. (MRK), and Teva Pharmaceutical (TEVA) could be profitable investments. Read on.

StockNews.com

3 Best Biotech Stocks for Growth in 2023

The biotech industry is well-positioned for solid growth due to the growing demand for high-quality treatments for chronic diseases and an aging population. Therefore, it could be wise to invest in fundamentally strong biotech stocks Jazz Pharmaceuticals (JAZZ), Alkermes (ALKS), and Gilead Sciences (GILD), given their solid growth prospects. Read…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer Inc. (PFE) vs. Teva Pharmaceutical Industries (TEVA): Which Stock is the Better Growth AND Value Buy?

The pharmaceutical sector appears to be in a favorable position for sustained long-term expansion. While leading pharma stocks Pfizer (PFE) and Teva Pharmaceuticals (TEVA) should benefit from the industry tailwinds, let us analyze which is the better buy for Growth and Value.

StockNews.com

Teva to pay $225M to settle cholesterol drug price-fixing charges

The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to sales of a widely used cholesterol-lowering drug

The Independent UK

Which is the Better Value Stock for August: Catalyst Pharmaceuticals, Inc. (CPRX) vs. Teva Pharmaceutical Industries (TEVA)?

Fueled by steady demand, the pharmaceutical sector has shown resilience and expansion even in an uncertain economic environment. Amid this scenario, Catalyst Pharmaceuticals (CPRX) and Teva Pharmaceuticals (TEVA) are set to reap the rewards. However, which of the two is the better value stock for August? Read more to find…

StockNews.com

Teva Retakes Its 200-Day Line After Second-Quarter Beat And Raise

Teva stock retook its 200-day moving average early Wednesday after the generic drugs giant beat second-quarter estimates.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

HOKA Shoes Maker Deckers Outdoor Posts 45% Profit Growth

Deckers Outdoor's HOKA shoe sales grew 27% in its latest quarter. Shares are near a 52-week high.

Investors Business Daily

The ES Shopping Shortlist: What to shop, see and know in June 2023

These are the hot-off-the-press launches to know

Evening Standard

Teva Undercuts Its 50-Day Line On Flat Sales As Profit Misses Forecasts

Teva Pharmaceutical reported lighter-than-expected earnings for the first quarter, leading Teva stock to plunge Wednesday.

Investors Business Daily

Best festival outfits of 2023 from crochet to sequins

Going all out is the aim of the game

Evening Standard

Best sandals for men to get set for the summer months

Start the season with the right foot forward

Evening Standard

The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat

Millions of people are scrambling to navigate the Adderall shortage in a saga closely watched by investors in Teva and other drug stocks. Here's what you should know.

Investors Business Daily

3 Stocks with More Upside Potential

Coupled with macroeconomic headwinds, the sudden regional banking failures have marred investor sentiments. Moreover, amid anticipations of a recession, the existing market volatilities are not likely to subside anytime soon. Given this backdrop, we think the strong growth prospects of Gilead Sciences (GILD), Teva Pharmaceutical (TEVA), and MacroGenics (MGNX) make…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

Chicago Sun-Times

Chicago is seeing an increase in fatal meth overdoses. Here’s why.

110 people in Chicago died from methamphetamine overdoses in 2021, a steep rise from 47 in 2019. The fatal overdoses are linked to a rise in demand, increased supply and deadlier “cocktails” as dealers cut the drug with fentanyl and cocaine.

Investors Business Daily

Teva Plots Its Knockoff Of Axsome's New Depression Drug, Sending The Biotech Sprawling

Teva Pharmaceutical said Monday it plans to make a knockoff of Axsome Therapeutics' new depression treatment, leading AXSM stock to tumble.

Investors Business Daily

Teva Guides To Its First Year Of Growth Since 2017 — But Shares Tumbled On This Caveat

Teva expects 2023 sales to grow for the first time in six years, but the guidance comes with one notable caveat and Teva stock fell.

Investors Business Daily

No. 1 IBD 50 Stock Catalyst Tanks As Teva Looks To Knock Off Its Only Product

Teva said Monday it plans to knock off Catalyst's only approved drug and CPRX stock — which has sat atop the IBD 50 for weeks — crashed.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

4 Pharma Stocks You Shouldn’t Think Twice About Buying in 2023

Pharma sector usually performs relatively well amid market turmoil due to the inelastic demand for its offerings. Moreover, increased technological advancements should boost the industry’s growth. Hence, pharma stocks Eli Lilly (LLY), AstraZeneca (AZN), Zoetis (ZTS), and Teva Pharmaceutical (TEVA) might be worth buying in 2023. Read more.

The Guardian - AU

‘It’s fun, it’s versatile, it’s functional’: terry towelling’s time in the sun

Emerging designers are putting a sustainable twist on the quintessentially 70s fabric, that’s practical at the beach and playful off it

StockNews.com

4 Stocks to Buy Before the Next Big Bull Rally

Cooling inflationary pressures and the Fed’s indication of a slower pace of rate hikes ahead could generate a potential bull rally this month. So, we believe investors should load up on fundamentally strong stocks General Motors Company (GM), BorgWarner Inc. (BWA), Teva Pharmaceutical Industries Limited (TEVA), and Rambus Inc. (RMBS).…

StockNews.com

4 Stocks to Amplify Your Portfolio in Q4

With investors regaining confidence in the markets amid cooling down inflation, fundamentally strong stocks CSX Corporation (CSX), Teva Pharmaceutical Industries (TEVA), Celestica Inc. (CLS), and DLH Holdings (DLHC) may be ideal investments to capitalize on their potential rebound. Continue reading….

Benzinga

Troubled FTX Faces SEC Probe And 'Urgently Needs' $8B To Avoid Bankruptcy, NIO Posts Wider Q3 Loss, AstraZeneca Ditches US Application Submission For COVID-19 Shot: Top Stories Thursday, Nov. 11

Bloomberg

StockNews.com

4 Health Care Stocks That Could Keep Your Portfolio From Needing a Check-Up

The healthcare industry tends to withstand macroeconomic pressure better than other industries due to the almost inelastic demand for medical products and services. With a recession expected next year, investors could look to capitalize on the defensive characteristics and long-term prospects of the industry by investing in quality medical stocks…

The Independent UK

New York could get $524M under opioid settlements with Teva

New York Attorney General Letitia James says the state will receive up to $524 million from drugmaker Teva to settle claims that the company contributed to the U.S. opioid epidemic

1 2 3 4 5

People

Dipanjan BanchurSince

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.